Lina Li | Associate Director, IR |
John Leonard | President and Chief Executive Officer |
Laura Sepp-Lorenzino | Executive Vice President and Chief Scientific Officer |
Glenn Goddard | Executive Vice President, Chief Financial Officer |
David Lebwohl | Executive Vice President and Chief Medical Officer |
Salveen Richter | Goldman Sachs |
Maury Raycroft | Jefferies |
Madhu Kumar | Robert W. Baird & Co. |
Gena Wang | Barclays |
Joon Lee | Truist |
Steven Seedhouse | Raymond James |
Yanan Zhu | Wells Fargo |
Good morning. My name is Drew, and I will be your conference operator today and welcome to the Intellia Therapeutics Third Quarter 2020 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Following the formal remarks we will open the call up for your questions. Please be advised that this call is being recorded at the company's request.